Trevi Therapeutics TRVI
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q2 | 5.47 | -0.09 | -13,722 | -12 | ||
| 2025Q1 | 6.29 | 110.81 | -0.09 | -11,470 | -10 | |
| 2024Q4 | 4.12 | 107.41 | -0.11 | -12,243 | -11 | |
| 2024Q3 | 3.34 | 106.14 | -0.13 | -14,086 | -13 | |
| 2024Q2 | 2.98 | 107.52 | -0.12 | -13,289 | -12 | |
| 2024Q1 | 3.45 | 109.14 | -0.11 | -11,906 | -11 | |
| 2023Q4 | 1.34 | 114.54 | -0.08 | -8,933 | -8 | |
| 2023Q3 | 2.18 | 117.35 | -0.07 | -9,045 | -8 | |
| 2023Q2 | 2.39 | 119.37 | -0.08 | -8,382 | -7 | |
| 2023Q1 | 1.85 | 122.44 | -0.06 | -7,563 | -6 | |
| 2022Q4 | 1.93 | 126.78 | -0.01 | -6,657 | -6 | |
| 2022Q3 | 1.54 | 105.31 | -0.10 | -8,405 | -8 | |
| 2022Q2 | 2.81 | 100.76 | -0.10 | -7,820 | -8 | |
| 2022Q1 | 2.20 | 99.90 | -0.24 | -7,025 | -7 | |
| 2021Q4 | 0.78 | 100.68 | -0.24 | -8,273 | -9 | |
| 2021Q3 | 1.40 | 99.96 | -0.33 | -6,947 | -7 | |
| 2021Q2 | 2.25 | 96.49 | -0.49 | -9,167 | -10 | |
| 2021Q1 | 2.71 | 99.96 | -0.43 | -8,089 | -8 | |
| 2020Q4 | 2.42 | 99.95 | -0.51 | -9,193 | -10 | |
| 2020Q3 | 4.03 | 100.04 | -0.41 | -7,244 | -7 |